Page last updated: 2024-08-21

diphenylamine and Angiosarcoma

diphenylamine has been researched along with Angiosarcoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersen, NJ; Baker, LH; Boguslawski, EA; Dawes, MJ; Duesbery, NS; Dykema, KJ; Froman, RE; Furge, KA; Kamstock, DA; Kitchell, BE; Krivochenitser, RI; Nickoloff, BJ; Thomas, DG	1
Andersen, NJ; Boguslawski, EB; Chambers, CM; Duesbery, NS; Kuk, CY	1

Other Studies

2 other study(ies) available for diphenylamine and Angiosarcoma

Article	Year
Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma. Molecular cancer therapeutics, 2013, Volume: 12, Issue:9 Topics: Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; Diphenylamine; Disease Models, Animal; Dogs; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Hemangiosarcoma; Humans; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Niacinamide; Phenylurea Compounds; Signal Transduction; Sorafenib; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2013
Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts. International journal of oncology, 2015, Volume: 47, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Diphenylamine; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Hemangiosarcoma; Humans; Melanoma; Mice; Mitogen-Activated Protein Kinase Kinases; Sirolimus; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2015

Article

Year

Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma.

Molecular cancer therapeutics, 2013, Volume: 12, Issue:9

Topics: Animals; Antineoplastic Agents; Benzamides; Cell Proliferation; Diphenylamine; Disease Models, Animal; Dogs; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Hemangiosarcoma; Humans; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Niacinamide; Phenylurea Compounds; Signal Transduction; Sorafenib; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2013

Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts.

International journal of oncology, 2015, Volume: 47, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Diphenylamine; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Hemangiosarcoma; Humans; Melanoma; Mice; Mitogen-Activated Protein Kinase Kinases; Sirolimus; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2015